Verastem, Inc. Total Assets
Verastem, Inc. (VSTM) had Total Assets of $206.51 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $206.51M.
- 2026-03-31: Assets $227.81M.
- 2025-12-31: Assets $246.44M.
- 2025-09-30: Assets $176.85M.
| Period end | Assets |
|---|---|
| 2026-06-30 | $206.51M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $227.81M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $246.44M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $176.85M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $196.26M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $131.70M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $101.54M 10-K · filed 2026-03-04 |
| 2024-09-30 | $126.38M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $105.75M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $123.54M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $149.72M 10-K · filed 2025-03-20 |
| 2023-09-30 | $176.15M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $191.76M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $120.88M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $95.05M 10-K · filed 2024-03-14 |
| 2022-09-30 | $111.09M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $100.41M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $116.15M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $108.66M 10-K · filed 2023-03-14 |
| 2021-09-30 | $111.88M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $123.89M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $136.90M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $154.35M 10-K · filed 2022-03-28 |
| 2020-09-30 | $217.77M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $198.53M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $208.15M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $145.05M 10-K · filed 2021-03-18 |
| 2019-09-30 | $192.60M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $218.54M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $243.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $277.24M 10-K · filed 2020-03-11 |
| 2018-09-30 | $183.16M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $172.92M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $68.41M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $89.79M 10-K · filed 2019-03-12 |
| 2017-09-30 | $63.14M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $61.84M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $76.25M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $83.63M 10-K · filed 2018-03-13 |
| 2016-09-30 | $89.04M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $95.42M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $102.56M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $113.09M 10-K · filed 2017-03-23 |
| 2015-09-30 | $123.67M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $135.70M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $142.00M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $98.65M 10-K · filed 2016-03-03 |
| 2014-09-30 | $97.88M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $107.34M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $115.73M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $125.26M 10-K · filed 2015-03-10 |
| 2013-09-30 | $132.43M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $79.96M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $86.24M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $92.92M 10-K · filed 2014-03-06 |
| 2012-09-30 | $98.83M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $105.66M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $110.70M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $59.04M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |